3 results
ARS
2023 FY
CRBU
Caribou Biosciences Inc
25 Apr 24
Annual report to shareholders
4:06pm
voluntarily follow them. Furthermore, the Food and Drug Omnibus Reform Act of 2022 requires clinical trial sponsors to submit a diversity action plan … such a diversity action plan, or if such implementation would be against the interest of public health during a public health emergency. Unless the FDA has
ARS
2022 FY
CRBU
Caribou Biosciences Inc
28 Apr 23
Annual report to shareholders
12:00am
to submit a diversity action plan for clinical trials, unless a waiver is granted by the FDA for reasons such as prevalence of the disease … or condition, impracticality of implementing such a diversity action plan, or if such implementation would be against the interest of public health during
- Prev
- 1
- Next